Report Detail

Request for Sample of this report

Other Global (United States, European Union and China) Vial and Prefilled Syringe Market Research Report 2019-2025

  • RnM3446624
    • |
  • 29 May, 2020
    • |
  • Global
    • |
  • 106 Pages
    • |
  • QYResearch
    • |
  • Other

This report covers market size and forecasts of Vial and Prefilled Syringe, including the following market information:
Global Vial and Prefilled Syringe Market Size, 2019-2021, and 2020 (quarterly data), (US$ Million) & (K Units)
Global Vial and Prefilled Syringe Market Size by Type and by Application, 2019-2021, and 2020 (quarterly data), (US$ Million) & (K Units)
Global Vial and Prefilled Syringe Market Size by Region (and Key Countries), 2019-2021, and 2020 (quarterly data), (US$ Million) & (K Units)
Global Vial and Prefilled Syringe Market Size by Company, 2019- 2020 (quarterly data), (US$ Million) & (K Units)

Key market players
Major competitors identified in this market include BD (US), Gerresheimer (DE), Nipro Corporation (JP), Schott forma vitrum (DE), Ompi (IT), Baxter BioPharma Solution (US), ROVI CM (ES), Terumo (JP), Vetter (DE), Unilife Corporation (US), Taisei Kako (JP), Roselabs Group (IN), ARTE CORPORATION (JP), Weigao Group Medical Polymer (CN), Zibo Minkang Pharmaceutical (CN), Shandong Pharmaceutical Glass (CN), etc.

Based on the Region:
Asia-Pacific (China, Japan, South Korea, India and ASEAN)
North America (US and Canada)
Europe (Germany, France, UK and Italy)
Rest of World (Latin America, Middle East & Africa)

Based on the Type:
Glass Vial and Prefilled Syringe
Polymer Vial and Prefilled Syringe

Based on the Application:
Antithrombotics
Vaccines
Autoimmune Diseases
Anti-inflammatory Drugs
Other


  • 1.1 Research Scope
  • 1.2 Market Segmentation
  • 1.3 Research Objectives
  • 1.4 Research Methodology
    • 1.4.1 Research Process
    • 1.4.2 Data Triangulation
    • 1.4.3 Research Approach
    • 1.4.4 Base Year
  • 1.5 Coronavirus Disease 2019 (Covid-19) Impact Will Have a Severe Impact on Global Growth
    • 1.5.1 Covid-19 Impact: Global GDP Growth, 2019, 2020 and 2021 Projections
    • 1.5.2 Covid-19 Impact: Commodity Prices Indices
    • 1.5.3 Covid-19 Impact: Global Major Government Policy
  • 1.6 The Covid-19 Impact on Vial and Prefilled Syringe Industry
  • 1.7 COVID-19 Impact: Vial and Prefilled Syringe Market Trends

    • 2 Global Vial and Prefilled Syringe Quarterly Market Size Analysis

    • 2.1 Vial and Prefilled Syringe Business Impact Assessment - COVID-19
      • 2.1.1 Global Vial and Prefilled Syringe Market Size, Pre-COVID-19 and Post- COVID-19 Comparison, 2015-2026
      • 2.1.2 Global Vial and Prefilled Syringe Price, Pre-COVID-19 and Post- COVID-19 Comparison, 2015-2026
    • 2.2 Global Vial and Prefilled Syringe Quarterly Market Size 2020-2021
    • 2.3 COVID-19-Driven Market Dynamics and Factor Analysis
      • 2.3.1 Drivers
      • 2.3.2 Restraints
      • 2.3.3 Opportunities
      • 2.3.4 Challenges

    3 Quarterly Competitive Assessment, 2020

    • 3.1 Global Vial and Prefilled Syringe Quarterly Market Size by Manufacturers, 2019 VS 2020
    • 3.2 Global Vial and Prefilled Syringe Factory Price by Manufacturers
    • 3.3 Location of Key Manufacturers Vial and Prefilled Syringe Manufacturing Factories and Area Served
    • 3.4 Date of Key Manufacturers Enter into Vial and Prefilled Syringe Market
    • 3.5 Key Manufacturers Vial and Prefilled Syringe Product Offered
    • 3.6 Mergers & Acquisitions, Expansion Plans

    4 Impact of Covid-19 on Vial and Prefilled Syringe Segments, By Type

    • 4.1 Introduction
      • 1.4.1 Glass Vial and Prefilled Syringe
      • 1.4.2 Polymer Vial and Prefilled Syringe
    • 4.2 By Type, Global Vial and Prefilled Syringe Market Size, 2019-2021
      • 4.2.1 By Type, Global Vial and Prefilled Syringe Market Size by Type, 2020-2021
      • 4.2.2 By Type, Global Vial and Prefilled Syringe Price, 2020-2021

    5 Impact of Covid-19 on Vial and Prefilled Syringe Segments, By Application

    • 5.1 Overview
      • 5.5.1 Antithrombotics
      • 5.5.2 Vaccines
      • 5.5.3 Autoimmune Diseases
      • 5.5.4 Anti-inflammatory Drugs
      • 5.5.5 Other
    • 5.2 By Application, Global Vial and Prefilled Syringe Market Size, 2019-2021
      • 5.2.1 By Application, Global Vial and Prefilled Syringe Market Size by Application, 2019-2021
      • 5.2.2 By Application, Global Vial and Prefilled Syringe Price, 2020-2021

    6 Geographic Analysis

    • 6.1 Introduction
    • 6.2 North America
      • 6.2.1 Macroeconomic Indicators of US
      • 6.2.2 US
      • 6.2.3 Canada
    • 6.3 Europe
      • 6.3.1 Macroeconomic Indicators of Europe
      • 6.3.2 Germany
      • 6.3.3 France
      • 6.3.4 UK
      • 6.3.5 Italy
    • 6.4 Asia-Pacific
      • 6.4.1 Macroeconomic Indicators of Asia-Pacific
      • 6.4.2 China
      • 6.4.3 Japan
      • 6.4.4 South Korea
      • 6.4.5 India
      • 6.4.6 ASEAN
    • 6.5 Rest of World
      • 6.5.1 Latin America
      • 6.5.2 Middle East and Africa

    7 Company Profiles

    • 7.1 BD (US)
      • 7.1.1 BD (US) Business Overview
      • 7.1.2 BD (US) Vial and Prefilled Syringe Quarterly Production and Revenue, 2020
      • 7.1.3 BD (US) Vial and Prefilled Syringe Product Introduction
      • 7.1.4 BD (US) Response to COVID-19 and Related Developments
    • 7.2 Gerresheimer (DE)
      • 7.2.1 Gerresheimer (DE) Business Overview
      • 7.2.2 Gerresheimer (DE) Vial and Prefilled Syringe Quarterly Production and Revenue, 2020
      • 7.2.3 Gerresheimer (DE) Vial and Prefilled Syringe Product Introduction
      • 7.2.4 Gerresheimer (DE) Response to COVID-19 and Related Developments
    • 7.3 Nipro Corporation (JP)
      • 7.3.1 Nipro Corporation (JP) Business Overview
      • 7.3.2 Nipro Corporation (JP) Vial and Prefilled Syringe Quarterly Production and Revenue, 2020
      • 7.3.3 Nipro Corporation (JP) Vial and Prefilled Syringe Product Introduction
      • 7.3.4 Nipro Corporation (JP) Response to COVID-19 and Related Developments
    • 7.4 Schott forma vitrum (DE)
      • 7.4.1 Schott forma vitrum (DE) Business Overview
      • 7.4.2 Schott forma vitrum (DE) Vial and Prefilled Syringe Quarterly Production and Revenue, 2020
      • 7.4.3 Schott forma vitrum (DE) Vial and Prefilled Syringe Product Introduction
      • 7.4.4 Schott forma vitrum (DE) Response to COVID-19 and Related Developments
    • 7.5 Ompi (IT)
      • 7.5.1 Ompi (IT) Business Overview
      • 7.5.2 Ompi (IT) Vial and Prefilled Syringe Quarterly Production and Revenue, 2020
      • 7.5.3 Ompi (IT) Vial and Prefilled Syringe Product Introduction
      • 7.5.4 Ompi (IT) Response to COVID-19 and Related Developments
    • 7.6 Baxter BioPharma Solution (US)
      • 7.6.1 Baxter BioPharma Solution (US) Business Overview
      • 7.6.2 Baxter BioPharma Solution (US) Vial and Prefilled Syringe Quarterly Production and Revenue, 2020
      • 7.6.3 Baxter BioPharma Solution (US) Vial and Prefilled Syringe Product Introduction
      • 7.6.4 Baxter BioPharma Solution (US) Response to COVID-19 and Related Developments
    • 7.7 ROVI CM (ES)
      • 7.7.1 ROVI CM (ES) Business Overview
      • 7.7.2 ROVI CM (ES) Vial and Prefilled Syringe Quarterly Production and Revenue, 2020
      • 7.7.3 ROVI CM (ES) Vial and Prefilled Syringe Product Introduction
      • 7.7.4 ROVI CM (ES) Response to COVID-19 and Related Developments
    • 7.8 Terumo (JP)
      • 7.8.1 Terumo (JP) Business Overview
      • 7.8.2 Terumo (JP) Vial and Prefilled Syringe Quarterly Production and Revenue, 2020
      • 7.8.3 Terumo (JP) Vial and Prefilled Syringe Product Introduction
      • 7.8.4 Terumo (JP) Response to COVID-19 and Related Developments
    • 7.9 Vetter (DE)
      • 7.9.1 Vetter (DE) Business Overview
      • 7.9.2 Vetter (DE) Vial and Prefilled Syringe Quarterly Production and Revenue, 2020
      • 7.9.3 Vetter (DE) Vial and Prefilled Syringe Product Introduction
      • 7.9.4 Vetter (DE) Response to COVID-19 and Related Developments
    • 7.10 Unilife Corporation (US)
      • 7.10.1 Unilife Corporation (US) Business Overview
      • 7.10.2 Unilife Corporation (US) Vial and Prefilled Syringe Quarterly Production and Revenue, 2020
      • 7.10.3 Unilife Corporation (US) Vial and Prefilled Syringe Product Introduction
      • 7.10.4 Unilife Corporation (US) Response to COVID-19 and Related Developments
    • 7.11 Taisei Kako (JP)
      • 7.11.1 Taisei Kako (JP) Business Overview
      • 7.11.2 Taisei Kako (JP) Vial and Prefilled Syringe Quarterly Production and Revenue, 2020
      • 7.11.3 Taisei Kako (JP) Vial and Prefilled Syringe Product Introduction
      • 7.11.4 Taisei Kako (JP) Response to COVID-19 and Related Developments
    • 7.12 Roselabs Group (IN)
      • 7.12.1 Roselabs Group (IN) Business Overview
      • 7.12.2 Roselabs Group (IN) Vial and Prefilled Syringe Quarterly Production and Revenue, 2020
      • 7.12.3 Roselabs Group (IN) Vial and Prefilled Syringe Product Introduction
      • 7.12.4 Roselabs Group (IN) Response to COVID-19 and Related Developments
    • 7.13 ARTE CORPORATION (JP)
      • 7.13.1 ARTE CORPORATION (JP) Business Overview
      • 7.13.2 ARTE CORPORATION (JP) Vial and Prefilled Syringe Quarterly Production and Revenue, 2020
      • 7.13.3 ARTE CORPORATION (JP) Vial and Prefilled Syringe Product Introduction
      • 7.13.4 ARTE CORPORATION (JP) Response to COVID-19 and Related Developments
    • 7.14 Weigao Group Medical Polymer (CN)
      • 7.14.1 Weigao Group Medical Polymer (CN) Business Overview
      • 7.14.2 Weigao Group Medical Polymer (CN) Vial and Prefilled Syringe Quarterly Production and Revenue, 2020
      • 7.14.3 Weigao Group Medical Polymer (CN) Vial and Prefilled Syringe Product Introduction
      • 7.14.4 Weigao Group Medical Polymer (CN) Response to COVID-19 and Related Developments
    • 7.15 Zibo Minkang Pharmaceutical (CN)
      • 7.15.1 Zibo Minkang Pharmaceutical (CN) Business Overview
      • 7.15.2 Zibo Minkang Pharmaceutical (CN) Vial and Prefilled Syringe Quarterly Production and Revenue, 2020
      • 7.15.3 Zibo Minkang Pharmaceutical (CN) Vial and Prefilled Syringe Product Introduction
      • 7.15.4 Zibo Minkang Pharmaceutical (CN) Response to COVID-19 and Related Developments
    • 7.16 Shandong Pharmaceutical Glass (CN)
      • 7.16.1 Shandong Pharmaceutical Glass (CN) Business Overview
      • 7.16.2 Shandong Pharmaceutical Glass (CN) Vial and Prefilled Syringe Quarterly Production and Revenue, 2020
      • 7.16.3 Shandong Pharmaceutical Glass (CN) Vial and Prefilled Syringe Product Introduction
      • 7.16.4 Shandong Pharmaceutical Glass (CN) Response to COVID-19 and Related Developments

    8 Supply Chain and Sales Channels Analysis

    • 8.1 Vial and Prefilled Syringe Supply Chain Analysis
      • 8.1.1 Vial and Prefilled Syringe Supply Chain Analysis
      • 8.1.2 Covid-19 Impact on Vial and Prefilled Syringe Supply Chain
    • 8.2 Distribution Channels Analysis
      • 8.2.1 Vial and Prefilled Syringe Distribution Channels
      • 8.2.2 Covid-19 Impact on Vial and Prefilled Syringe Distribution Channels
      • 8.2.3 Vial and Prefilled Syringe Distributors
    • 8.3 Vial and Prefilled Syringe Customers

    9 Key Findings

      10 Appendix

      • 10.1 About Us

      Summary:
      Get latest Market Research Reports on Vial and Prefilled Syringe . Industry analysis & Market Report on Vial and Prefilled Syringe is a syndicated market report, published as Global (United States, European Union and China) Vial and Prefilled Syringe Market Research Report 2019-2025. It is complete Research Study and Industry Analysis of Vial and Prefilled Syringe market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.

      Last updated on

      REPORT YOU MIGHT BE INTERESTED

      Purchase this Report

      		$3,250.00
      		$4,875.00
      		$6,500.00
      		2,512.25
      		3,768.38
      		5,024.50
      		3,025.75
      		4,538.63
      		6,051.50
      		496,242.50
      		744,363.75
      		992,485.00
      		274,300.00
      		411,450.00
      		548,600.00
      Credit card Logo
      Sample Question Discount Download PDF

      Related Reports

      Reason to Buy

      • Trusted By Leaders

        Top executives from leading companies purchase research reports from us. 

      • Shop With Confidence

        We assist you with all the pre-sales enquiries related to any report so that you can buy with confidence.

      • Customer Centric

        Need assistance related to your research requirements? We are just a phone call or an email away.

      • Personalized Solutions

        Our experienced research specialists are here to help you locate the right reports for your need.

      • Secure Checkout

        Shop without being worried about safety & security of your transactions.
        •

      Request for Sample of this report

      Reports and Markets

      mcafree

      Contact Us

      +1-352-353-0818 (US)

      info@reportsandmarkets.com

      Support

      EMAIL US

      Newsletter

      KEEP UP TO DATE ON ALL THE LATEST REPORTS


      maxmind_logo